342 Results for "

compound 10

" in MedChemExpress (MCE) Product Catalog:
Products (342)

342 Results for "compound 10" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-120323
CAS No.: 2101765-81-3
Purity:  98.11%
Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

DRI-C21045 (compound 10) is a potent and selective inhibitor of the CD40-CD40L costimulatory protein-protein interaction (PPI) with an IC50 of 0.17 μM. DRI-C21045 shows concentration-dependent inhibition of the activation of NF-κB and B cell proliferation all induced by CD40L with IC50s of 17.1 μM and 4.5 μM, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-102031
CAS No.: 1702816-75-8
Purity:  98.91%
Synonyms: YY-20394
Target:  

PI3K

Research Areas:  

Inflammation/Immunology Cancer

Linperlisib (YY-20394) is a potent, orally bioavailable and selective inhibitor of PI3Kδ extracted from patent WO 2015055071 A1, compound 10; has an IC50 of 6.4 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153016
CAS No.: 2750141-15-0
Purity:  99.59%
Research Areas:  

Inflammation/Immunology

HIF-2α agonist 2 (compound 10) is a HIF-2α agonist with an EC50 value of 1.68 μM at the dose of 20 μM. HIF-2α agonist 2 is non-cytotoxic against 786-O-HRE-Luc cells. HIF-2α agonist 2 can be used for oxygen metabolism research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-139781
CAS No.: 2767424-13-3
Purity:  98.01%
Target:  

PD-1/PD-L1 Apoptosis

Research Areas:  

Cancer

PD-L1-IN-1 (Compound 10) is a potent PD-L1 inhibitor with an IC50 of 115 nM. PD-L1-IN-1 strongly binds with the PD-L1 protein and challenged it in a co-culture of PD-L1 expressing cancer cells and peripheral blood mononuclear cells enhanced antitumor immune activity of the latter. PD-L1-IN-1 significantly exhibits low cytotoxicity in healthy cells .
loading...
    loading...
Cat. No.: HY-10072
CAS No.: 219773-55-4
Purity:  99.86%
Target:  

NF-κB AP-1

Research Areas:  

Inflammation/Immunology

SPC 839 (compound 10) is an orally active inhibitor of AP-1 and NF-kB mediated transcriptional activation with IC50 of 0.008 μM .
loading...
    loading...
Cat. No.: HY-N3872
CAS No.: 3198-49-0
Ethyl β-D-glucopyranoside (compound 10) is an ethyl derivative. Ethyl β-D-glucopyranoside can be isolated from ethanolic extract of Scabiosa stellata LS.
loading...
    loading...
Cat. No.: HY-147028
CAS No.: 785705-53-5
Purity:  98.95%
Target:  

mAChR

Research Areas:  

Neurological Disease

M4 mAChR agonist-1 (compound 10a) is a potent M4 mAChR agonist with an EC50 >10 μM for human M4 .
loading...
    loading...
Cat. No.: HY-176976
CAS No.: 3076725-05-5
Research Areas:  

Cancer

Exatecan-mpGNNG (Compound 10a) is the linker-payload component of an antibody-drug conjugate (ADC). Exatecan-mpGNNG is composed of Exatecan (HY-13631), a potent topoisomerase I inhibitor, and the linker .
loading...
    loading...
Cat. No.: HY-155403
CAS No.: 1241494-17-6
Purity:  99.58%
Research Areas:  

Neurological Disease

SCD1/5-IN-1 (Compound 10) is a SCD1/5 inhibitor. SCD1/5-IN-1 can be used for research of neurological disease .
loading...
    loading...
Cat. No.: HY-D2418
CAS No.: 2351933-31-6
PS-SCOTfluor-12 (compound 10) is a fluorescent probe for imaging Lactic acid (HY-B2227) metabolism in live cells. λex/λem= 485/605 nm .
loading...
    loading...
Cat. No.: HY-N10488
CAS No.: 133740-30-4
BChE-IN-11 (compound 10) is a potent, selective and non-competitive BChE (butyrylcholinesterase) inhibitor, with an IC50 of 2.1 μM. BChE-IN-11 can be used for Alzheimer's disease (AD) research .
loading...
    loading...
Cat. No.: HY-158005
Target:  

Apoptosis

Research Areas:  

Cancer

Anticancer agent 195 (Compound 10) is an inhibitor for ELF3-MED23 PPI with Ki of 0.68 μM. Anticancer agent 195 induces apoptosis and exhibits antitumor activity .
loading...
    loading...
Cat. No.: HY-108697A
CAS No.: 1672662-07-5
Purity:  99.84%
Research Areas:  

Cancer

(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC50 of 0.01 μM .
loading...
    loading...
Cat. No.: HY-169915
CAS No.: 2643320-62-9
Target:  

Aminopeptidase

Research Areas:  

Inflammation/Immunology Cancer

ERAP1 modulator-2 (compound 10) is a potent ERAP1 inhibitor with an IC50 value of <100 nM .
loading...
    loading...
Cat. No.: HY-112428
CAS No.: 1862238-01-4
Target:  

Sirtuin

Research Areas:  

Inflammation/Immunology

Sirt2-IN-2 (Compound 10) is a selective Sirt2 inhibitor with an IC50 of 0.118 μM .
loading...
    loading...
Cat. No.: HY-152954
CAS No.: 1629227-34-4
Target:  

DAPK

Research Areas:  

Inflammation/Immunology

DRAK1/2-IN-1 (compound 10e) is an active dual DRAK1 and DRAK2 inhibitor with Kd values of 1 μM and 6 μM, respectively .
loading...
    loading...
Cat. No.: HY-138040
CAS No.: 2407829-65-4
Purity:  98.00%
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

CRBN modulator-1, a Thalidomide analog and a CRBN modulator extracted from WO2020006262A1, compound 10, has an IC50 of 3.5 μM and a Ki of 0.98 μM .
loading...
    loading...
Cat. No.: HY-147304
CAS No.: 1226901-43-4
Target:  

Bacterial

Research Areas:  

Others

BPH-1086 (compound 10) is an IspH inhibitor, IspH domain fused with ribosomal protein S1 (RPS1) can bind to mRNA or form part of the bacterial ribosome .
loading...
    loading...
Cat. No.: HY-146128
CAS No.: 2488372-34-3
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

Anti-hyperglycemic agent-1 (compound 10) is a potent α-Glucosidase inhibitor, with an IC50 of 0.53 μM. Anti-hyperglycemic agent-1 can be used for diabetes research .
loading...
    loading...
Cat. No.: HY-146214
CAS No.: 1908454-70-5
Target:  

CDK

Research Areas:  

Cancer

As a cdk4/6 inhibitor. Compounds 10B and 10C showed low nanomolar activity, ideal antiproliferative activity, excellent metabolic properties and acceptable pharmacokinetics on cdk4/6.
loading...
    loading...